DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00326209 (ClinicalTrials.gov)	December 22, 2005	12/5/2006	Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission	A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation	Ulcerative Colitis	Drug: Encapsulated Mesalamine Granules (eMG)	Bausch Health Americas, Inc.	NULL	Completed	18 Years	N/A	All	393	Phase 3	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

December 22, 2005

12/5/2006

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation

Ulcerative Colitis

Drug: Encapsulated Mesalamine Granules (eMG)

Bausch Health Americas, Inc.

NULL

Completed

18 Years

N/A

All

393

Phase 3

United States